Navigation Links
Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses
Date:6/5/2008

Robust Pipelines Across Seven MD&D Franchises Poised to Deliver Innovation

and Growth Consumer Leadership Positions Built on Superior Science and Technology

NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Johnson & Johnson is reviewing its Medical Devices & Diagnostics and Consumer businesses at a meeting with the investment community today, focusing on the strengths, strategies and innovations that will keep the broadly based health care business growing in the coming years. Senior leaders from the company are outlining strategies for two of the business segments that will enable the company to capitalize on growing demand in the $4 trillion global market for health care products and services. A similar review with the investment community last year highlighted the company's Pharmaceutical and Consumer segments.

The company presentations address recent product launches, development pipelines, and market strategies that these businesses are deploying to achieve long-term, faster-than-market, growth rates across their businesses. They include new ways the company is addressing chronic diseases related to cardiovascular disease, metabolic disease and ophthalmology in a more comprehensive way; new surgical products to address the growing demand in areas like orthopaedics, obesity and minimally invasive surgery; and the continuing application of superior science and technology to the company's broad range of consumer health care products.

"Johnson & Johnson remains a company committed to serving unmet health care needs with superior science and technology, while growing our businesses profitably for the long-term," said Dominic Caruso, Vice President, Finance, and Chief Financial Officer for Johnson & Johnson. "The businesses we are highlighting at today's meeting -- the world's largest medical technology business and premier consumer health care company -- develop important innovations for the benefit
'/>"/>

SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...s were more likely to consider change after 30-min... , FRIDAY, Nov. 27 (HealthDay News) -- A progr...why they should stop their dangerous behavior may ...archers have found. , The new study included 18...aired convictions, who were randomly assigned to o...
(Date:11/27/2009)...WNA, BC, Nov. 27 /PRNewswire/ - Uploadable USB ped...me time in wellness. A combination of advanced acc... are solving a long term concern over the accuracy...ately gauge and reward improved participation in a... one of the first wellness suppliers to integrate ...
(Date:11/27/2009)...HESTER, N.Y., Nov. 27 P... provider and fortunately every year, new vaccines...But do all vaccines boost immunity for the same pe...oster shots, needed to keep immunity strong? ,...l of the American Academy of Pediatrics, Michael P...
(Date:11/27/2009)...ling plus low-emission vehicles may reduce future ...AY, Nov. 27 (HealthDay News) -- Encouraging city d...would offer much greater public health benefits th...esearchers have found. , The study compared the...rban land transport scenarios for London, England,...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
..., Safety and Efficacy Study of Zolpidem Tartrate S...wakening on an As-Needed Basis , , Evaluation of ...sive Compulsive Disorder , , RICHMOND, Calif., Ma...etary products that address important therapeutic ...
..., Videotape The Silliest Sneeze You,ve Ever Seen F...Little Allergies(R) Allergen Block! , , Contest E....Y., May 21 Do your friends, family, or coworkers...Allergen Block , announce the launch of the first ...
...Procedure doubles odds for intensive care compared... , THURSDAY, May 21 (HealthDay News) -- Babies...livery are nearly twice as likely to be admitted t...ion babies are also more likely to have breathing ...
..., LAS VEGAS, May 21 CPC of America, Inc. (OTC Bul...of its first patent of a synthetic sealant for spe... focused on the development and testing of the Med...on, CPC is focused on the development of its own s...
..., PRINCETON, N.J., May 21 Celator Pharmaceuticals...ch agreement with Cephalon, Inc. (Nasdaq: CEPH )...tion of the application of Celator,s proprietary t...echnology and expertise at Celator beyond our own ...
..., - Bold and innovative marketing campaign will ta...of use and excellent tolerability - , , CORONA, C...in generic and specialty branded pharmaceuticals, ...h symptoms of urge urinary incontinence, urgency, ...
Other Medicine News:Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:If Heads Turn When You Sneeze, Enter the 'Side-Splitting Sneeze Contest' 2Health News:Risk to Baby Rises With Repeat C-Sections 2Health News:Risk to Baby Rises With Repeat C-Sections 3Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 2Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 3Health News:Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 4
(Date:11/26/2009)...frica, Nov. 26 The 2009 Frost &...in the Generic Pharmaceutical Market is presented ... http://www.newscom.com/cgi-bin/prnh/20081117/FSL... following criteria were used to benchmark Cipla M...h strategy and implementation, degree of innovatio...
(Date:11/25/2009)...25 American Scientific R...is pleased to announce that they have opened a reg...n Shanghai, China. ,, ASR has been able to secu...ay for the development and production of current a...and adults to be distributed and sold globally. C...
(Date:11/25/2009)...5 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...l Society of North America (RSNA) at McCormick Pla...9 to highlight our new SecurView(®) DX multim...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 1Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 3Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 4Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 1Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 2Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 3Bayer Diabetes Care Launches A1CNow 28R 29 SELFCHECK a New A1C Monitor for At Home Use 47720 4Scientists create metal that pumps liquid uphill 12431 1Scientists create metal that pumps liquid uphill 12431 2Scientists create metal that pumps liquid uphill 12431 3
...ODLANDS, Texas--(BUSINESS WIRE)--Apr 3, 2007 - Rep...nal results of a U.S.,Phase 2 study of Proellex(TM...s of uterine fibroids. This study suggests that,tr...ighly,significant improvement in symptoms associat...erated., Study Details and Results , This 12 week,...
...gs indicate early non-responders unlikely to subse... costs, and may benefit,from earlier change in tre..., 2007 /PRNewswire-FirstCall/,-- New data presente...nia Research (ICOSR) suggest that antipsychotic dr...thought, and,challenge the current schizophrenia t...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6
Reusable Template
MicroTouch LP (Low Profile) Stabilizer
Precision Stepper
SurePoint™ Stepper/Stabilizer EquipmentTable Mount
Medicine Products: